Call
+918447748545

Published on: Apr 04, 2020
2 minute read
By: Dr Rajan Choudhary

THE CHALLENGES FACED IN MAKING A VACCINE FOR COVID-19 — Part 2

Previously we’ve seen the difficulties researches face in trying to make a vaccine. But even if we make a vaccine, that’s just half the battle. Viruses are unique because they can mutate, and they can mutate to astonishing degrees. In humans mutations to tiny parts of our DNA can cause severe diseases or even death. In viruses mutations can change their structure, making them more infective and giving them a new coat. It gives them a survival advantage, the ability to evade our immune system and make our vaccines ineffective. This is why we need a new flu vaccine every year.

If it takes months to a year to develop a vaccine, it will be based off the virus found in December 2019. By this time the virus may have spread and mutated to such a degree that it is not effective. This does not mean all the effort was for nothing. Going through the steps and understanding the issues faced with making a COVID-19 vaccine can make the process quicker for subsequent vaccines against its mutated versions.

https://www.sciencealert.com/who-says-a-coronavirus-vaccine-is-18-months-away So Long to Develop a Vaccine

FAILURES FROM THE PAST

These issues were faced during the Ebola and Zika virus epidemics, and many large companies are understandably hesitant to develop vaccines for COVID-19. Ebola first broke out in 2014, and it was only in December 2019 that the first vaccine was approved for use by the European Commission and the United States. This is despite multiple large institutes in Canada and the UK working together to develop it.

13 different Ebola vaccine candidates had been identified soon after the outbreak, but none had been tested on humans. Unfortunately this is the most expensive part of development, and the area biopharmecuticals stand to loose the most money. Return on investments is also low, since epidemics usually take place in poorer countries, and the potential customers are unable to pay the high prices for these brand new treatments. It is an unfortunate realisation that research into medicines is driven by rich countries, for diseases that affect the rich.

https://newint.org/features/web-exclusive/2016/06/16/why-did-the-market-fail-to-produce-an-ebola-vaccine Ebola

WHERE ARE WE NOW?

This is all well and good, but what does it mean for COVID-19? We know we cannot rush a vaccine, because a poorly designed vaccine with unknown side effects can cause more harm than good, especially if given to children or the elderly. Currently the WHO are tracking 31 different attempts at making a COVID-19 vaccine, using different methods as discussed before. All of these are currently in the pre-clinical stage, focusing on isolating parts of the virus and creating a target the body will recognise and react to.

Researchers at the University of Queensland were one of the first to start using the genetic code of COVID-19, released openly by Chinese researchers. They have developed a test vaccine within 6 weeks using state-of-the-art genetic techniques, used for the first time. If animal models prove successful then human testing might begin within 6 months. In the pharmaceutical industry advancements this quick are almost unheard of.

Additionally over 293 clinical trials are taking place in China using existing drugs on the market. The advantage is we already know these drugs are safe to use in humans, but we are trying to work out if they will work against COVID-19. Some scientists are also looking at medications that were initially developed against SARS and MERS, but never completed because these outbreaks died down and the medication was no longer required.

https://www.aljazeera.com/news/2020/03/china-recovered-develop-effective-covid-19-treatments-200302082850237.html COVID-19 treatments

https://www.who.int/blueprint/priority-diseases/key-action/novel-coronavirus-landscape-ncov.pdf?ua=1 WHO news

https://www.theverge.com/2020/2/28/21156385/covid-coronavirus-vaccine-treatment-moderna-remdesivir-research COVID-19 treatment

Its not all doom and gloom. Challenges drive innovation, and we are already benefitting from this. New forms of genetic sequencing, new methods for extracting viral proteins, new techniques in creating a vaccine. These innovations are already benefitting us on the drive to create an effective vaccine for COVID-19, and they will benefit us in the future when the next pandemic hits.

Dr Rajan Choudhary, Product Manager Second Medic UK

www.secondmedic.com

Read Blog

Flexible Work Schedules with Telehealth Support: A Smarter Approach to Employee Wellbeing

The modern workplace is undergoing a significant transformation. Rigid office hours and traditional healthcare access models are giving way to flexible work schedules and digital health solutions. One of the most impactful combinations emerging in corporate wellness is flexible work schedules with telehealth support.

This integrated approach addresses two critical challenges faced by today’s workforce: work-life imbalance and delayed healthcare access.

Why Workplace Health Models Need to Change

According to NITI Aayog and EY-FICCI workforce reports, Indian employees face rising levels of:

work-related stress
lifestyle diseases
burnout
absenteeism

Long working hours, commuting stress and limited time for medical visits worsen health outcomes. Flexible work arrangements and telehealth support directly address these gaps.

What Are Flexible Work Schedules?

Flexible work schedules allow employees to:

adjust start and end times
work remotely or in hybrid formats
manage personal commitments alongside work

Flexibility empowers employees to align work with their physical and mental health needs.

Understanding Telehealth Support

Telehealth uses digital platforms to deliver healthcare services such as:

online doctor consultations
follow-up care
preventive health advice
mental health support

It eliminates geographical and time barriers to healthcare.

Why Combining Flexibility with Telehealth Works

Individually, flexibility and telehealth are beneficial. Together, they create a powerful wellness ecosystem.

This combination allows employees to:

consult doctors without taking leave
manage chronic conditions proactively
address early symptoms promptly
reduce healthcare delays

Health Benefits for Employees

Reduced Stress and Burnout

Flexible schedules reduce time pressure, while telehealth removes healthcare-related anxiety.

Improved Access to Preventive Care

Employees are more likely to seek early consultations when care is convenient.

Better Management of Chronic Conditions

Conditions like hypertension, diabetes and thyroid disorders require regular follow-up, which telehealth supports efficiently.

Enhanced Mental Wellbeing

Tele-mental health services enable confidential and timely support.

Improved Work-Life Balance

Employees can prioritise health without compromising job responsibilities.

Productivity Benefits for Employers

Reduced Absenteeism

Quick access to care reduces prolonged sick leave.

Improved Employee Engagement

Health-supported employees show higher motivation and loyalty.

Lower Healthcare Costs

Preventive care reduces long-term medical claims.

Strong Employer Branding

Wellness-focused policies attract and retain talent.

Evidence Supporting Flexible Work and Telehealth

According to WHO and Lancet workplace health studies:

flexible work reduces stress-related disorders
telehealth improves healthcare utilisation
preventive care lowers chronic disease burden

Indian corporate data mirrors these findings, especially in hybrid work environments.

Role in Preventive Healthcare

Preventive healthcare focuses on early risk identification and lifestyle management.

Flexible schedules with telehealth support:

encourage routine checkups
support ongoing health monitoring
enable early intervention

This aligns with India’s preventive healthcare priorities outlined by NITI Aayog.

Addressing Common Concerns

Productivity Loss Myth

Multiple studies show flexible work improves output rather than reducing it.

Quality of Telehealth

Telehealth is effective for most primary care and follow-up needs.

Data Security

Modern telehealth platforms follow strict privacy and data protection standards.

Ideal Use Cases in the Workplace

This model is particularly effective for:

IT and corporate offices
remote and hybrid teams
organisations with distributed workforce
high-stress work environments

Implementation Best Practices

To maximise impact:

set clear flexibility guidelines
integrate telehealth access into HR benefits
promote preventive consultations
track wellness metrics

Leadership support is key to adoption.

Long-Term Organisational Impact

Organisations adopting this model report:

improved employee health indicators
reduced burnout
stronger workplace culture
sustainable productivity gains

Wellbeing becomes a strategic advantage.

Conclusion

Flexible work schedules with telehealth support represent the future of employee wellbeing. By removing barriers to healthcare access and allowing employees control over their work routines, this approach promotes preventive care, reduces stress and enhances productivity. As workplaces evolve, integrating flexibility with digital health support is not just an employee benefit—it is a strategic investment in long-term organisational health and resilience.

References

World Health Organization (WHO) – Workplace Health Promotion Framework
Indian Council of Medical Research (ICMR) – Lifestyle Disease and Workforce Health Studies
NITI Aayog – Digital Health and Workplace Wellness Reports
Lancet – Telehealth and Workforce Productivity Research
EY-FICCI – Corporate Wellness and Future of Work Reports
Statista – Telehealth Adoption and Workforce Trends

Request A Callback

+91

By using this website/app, I confirm that I am at least 18 years old and consent to the processing of my personal data in accordance with the Terms of Service, Privacy Policy, and Declaration.